Company Overview and News
Investing in your 20s is not only smart, it’s exciting. The best part about creating a long-term portfolio — whether while going back to school or taking time off — is having the time to invest in undervalued companies. When looking at stocks to buy in your 20s, it’s all about opportunity cost, which is spent in spades throughout your late-teens and as an aimless 20-something. Long-term investors have the benefit of time, allowing them to ride out turbulence others can’t.
WFCNP FB NFLX GOOG GM BIDU WFC IBM TRIP WM EXPE BP BKNG GOOGL CVX SBUX PCLN
It has been about a month since the last earnings report for TripAdvisor (TRIP - Free Report) . Shares have added about 5.2% in that time frame, outperforming the S&P 500.
2018-08-14 seekingalpha - 9
Below is a look at the 30 best and 30 worst performing S&P 500 stocks on their earnings reaction days this season. DISH Network (NASDAQ:DISH) posted a one-day gain of 14.53% on August 3rd following earnings, and that has held up as the best performer in the S&P 500 this season. Advanced Micro Devices (NASDAQ:AMD) ranks second with a one-day gain of 14.33%.
HAL GJV GLW FB DISH NWSA TRIP NLSN AMD EXPE WHR HAS NWS TWTR KHC INTC EBAY
2018-08-11 seekingalpha - 1
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.
NPSNY TEAM FB AVRO IPO TRIP SRPT BOLD GS GOOGL NVS MSFT ABBV PFE ABBV IPZYF EBAY
Shares of Yelp (NASDAQ:YELP) are screaming higher Thursday, up more than 15% after the company reported second-quarter earnings results. Now trading near $44, is it possible for Yelp stock to rally to its former 52-week high at $48.40?
GOOGL TRIP GOOG
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB EXPE TRIP
Tripadvisor (NASDAQ:TRIP) CEO Steve Kaufer put on a confident game face in the wake of Thursday’s disappointing second-quarter report, but owners of TRIP stock — current or prospective — weren’t buying it.
EXPE BKNG GOOGL TRIP GOOG TRVG
2018-08-03 247wallst - 3
The major equity indexes were indicated marginally lower after the payrolls report looked light prior to adding in higher revisions. That said, the drops were small and the Nasdaq was indicated marginally positive. Investors have had less success buying the all the stock market dips in 2018 than in prior years. Many investors also are reconsidering how they want their investments positioned ahead of the midterm elections and with international trade concerns.
SYMC UAA TEVA TEVVF MS APRN RUN DATA TRIP SYF FUN EOG UA ETP TEVJF FNKO TRI FL
Good morning, and welcome to TripAdvisor's Second Quarter 2018 Earnings Conference Call. As a reminder, today's conference call is being recorded. At this time, I'd like to turn the conference call over to TripAdvisor's Vice President of Investor Relations, Mr. Will Lyons. Please go ahead.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to TRIP / TripAdvisor, Inc. on message board site Silicon Investor.
as of ET